Go to Polygence Scholars page
Kiera Sheth's cover illustration
Polygence Scholar2022
Kiera Sheth's profile

Kiera Sheth

Legacy Magnet AcademyClass of 2025California

About

Projects

  • "What are the primary immune cell mediators that cause or trigger IBD symptoms and how are these being used for targeted IBD therapy?" with mentor Miranda (Working project)

Project Portfolio

What are the primary immune cell mediators that cause or trigger IBD symptoms and how are these being used for targeted IBD therapy?

Started May 18, 2022

Abstract or project description

Though considered a rare disease, many adults in the United States are diagnosed with some form of Irritable Bowel Disease, also known as IBD. IBD refers to autoimmune inflammation localized in the gastrointestinal tract and can include the esophagus, intestines, and colon. IBD patients commonly experience stomach pains, loose stools, frequent bathroom usage, weight loss, and anemia. The symptoms are linked to inflammation caused by the immune system. The definite cause or causes of IBD is very vague, but the pathology of the disease can be traced to its immunology. The rapid rise of inflammation in IBD is based upon an overactive immune system, in which immune cells falsely trigger defensive immune cell mediators. Such immune cell mediators can be used to understand and develop possible targets for IBD treatments. The aim of this review paper is to explore the immunology background that is linked to the cause of IBD. This paper will seek to describe the immune cells and molecules that differentiate that link the different forms of IBD together. Further, I will explain the various forms of treatment that are currently being explored to target the immune system.  The overall goal for the review article is to describe how the immune system is causing the symptoms of IBD in a manner that is understandable to the general audience.